Alex DTx Platform

The smarter way to launch Digital Therapeutics.

We provide the platform that enables our partners to effectively and reliably launch new digital therapeutics (DTx) by leveraging existing insights, modules, processes and data.


Discover our Platform
Our Digital Therapeutics

Evidence-based digital interventions that deliver novel and personalized care

Digital Therapeutics (DTx) are evidence-based therapeutic interventions delivered as mobile software applications. They undergo rigorous clinical and regulatory review, ensuring the same high standards of efficacy and safety as with traditional drugs. A DTx can be prescribed by a physician alongside a drug or therapy or as a stand-alone treatment.

Learn more about DTx
Eila®

A complete smoking cessation program treating nicotine addiction

The comprehensive DTx will soon be available as a reimbursable prescription DiGA in Germany under the DVG law. The DTx is currently undergoing clinical trial and will be commercialized in collaboration with Pfizer.

In collaboration with:

Almee™

Prescription DTx to increase quality of life for PF patients.

The comprehensive DTx will provide treatment for currently undertreated symptoms associated with PF, such as low mood and anxiety, improving the patient's quality of life.

In collaboration with:

Alex – Quit Smoking

The all-inclusive digital quit smoking coach.

Currently available for download in over 150 countries globally through the Apple App Store and Google Play.

Go to alexquitsmoking.com

Empowering patients globally

With a patient-centric mentality, we are driven by our goal of delivering targeted personalized care. Our novel DTx treatments are developed in collaboration with patient groups and deliver targeted, personalized care to patients with overlooked symptoms.

More about us
Friends & Partners